Value, Affordability, and Decision Making

Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.

Insights

Setting the Right Discount Rate for HTA in the Slovak Republic

21 May 2023

Health interventions such as new medicines produce costs and health-related effects not only in the year they are introduced but in all future years until they…

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making
Publication

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

15 May 2023

In this report, we discuss best practices for RWE generation and the steps needed to enhance the assessment and use of quality RWE in reimbursement decisions.

Insights

How Restrictive are NICE ‘Optimised’ Decisions?

27 April 2023

NICE makes ‘optimised’ decisions to support use of medicines in smaller groups of patients. Between 2020 to 2022, 56% of optimised decisions recommended treatment for less than half of eligible patients.

Insights

Around The World in HTAs: Italy – What’s Next?

20 April 2023

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Claudio Jommi, Università del Piemonte Orientale Novara, and Martina Garau, OHE, take us to Italy.

Delivering the Triple Win: A Value-Based Approach to Pricing
Publication

Delivering the Triple Win: A Value-Based Approach to Pricing

20 April 2023

In this report, we investigate the theory and practice of value-based pricing in the pharmaceuticals industry, and provide recommendations for how implementation of value-based pricing can be enhanced to deliver the triple win of patient access; healthcare system sustainability; and innovation.

Close up of man holding DNA molecule in Glass bottle. Mixed medi
Event

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

19 April 2023

OHE experts in Boston provided insights about innovative approaches to reimbursement for cell and gene therapies

Event

Valuing Vaccines: The Economics of Vaccines & Immunisations

19 April 2023

Global experts discussed the value of equity in vaccine access worldwide and practitioners shared insights on economic evaluation in resource-constrained environments.

Insights

Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA

11 April 2023

Through a three-part webinar series, commissioned and funded by Roche, OHE has explored the burdens on informal carers when providing unpaid care for loved ones.

Spain
Insights

Around The World in HTAs: Spain – Are We There Yet?

15 March 2023

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Laura Vallejo-Torres, University of Las Palmas de Gran Canaria, and Patricia Cubi-Molla, OHE, take us to Spain.